Self-Assembled Nanoparticles Based on Amphiphilic Anticancer Drug-Phospholipid Complex for Targeted Drug Delivery and Intracellular Dual-Controlled Release

被引:66
作者
Li, Yang [1 ,2 ]
Lin, Jinyan [1 ,2 ]
Yang, Xiangrui [1 ]
Li, Yanxiu [1 ]
Wu, Shichao [1 ]
Huang, Yu [1 ]
Ye, Shefang [1 ]
Xie, Liya [3 ]
Dai, Lizong [1 ]
Hou, Zhenqing [1 ]
机构
[1] Xiamen Univ, Coll Mat, Xiamen 361005, Peoples R China
[2] Xiamen Univ, Coll Chem & Chem Engn, Dept Chem, Xiamen 361005, Peoples R China
[3] Xiamen Univ, Affiliated Hosp 1, Xiamen 361002, Peoples R China
基金
中国国家自然科学基金;
关键词
anticancer-phospholipid complex; self-assembly; nanoparticles; targeted drug delivery; sustained/controlled drug release; FUNCTIONALIZED NANOSCALE MICELLES; PLA HYBRID NANOPARTICLES; MITOMYCIN-C; TUMOR-CELLS; THERAPEUTICS; METHOTREXATE; INHIBITORS; EFFICACY; PRODRUG;
D O I
10.1021/acsami.5b05038
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Integrating advantages of mitomycin C (MMC)-phospholipid complex for increased drug encapsulation efficiency and reduced premature drug release, DSPE-PEG-folate (DSPE-PEG-FA) for specific tumor targeting, we reported a simple one-pot self-assembly route to prepare the MMC- phospholipid complex-loaded DSPE-PEG-based nanoparticles (MP-PEG-FA NPs). Both confocal imaging and flow cytometry demonstrated that MMC was distributed into nuclei after cellular uptake and intracellular drug delivery. More importantly, the systemically administered MP-PEG-FA NPs led to increased blood persistence and enhanced tumor accumulation in He La tumor-bearing nude mice. This study introduces a simple and effective strategy to design the anticancer drug phospholipid complex-based targeted drug delivery system for sustained/controlled drug release.
引用
收藏
页码:17573 / 17581
页数:9
相关论文
共 28 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   Ligand-targeted therapeutics in anticancer therapy [J].
Allen, TM .
NATURE REVIEWS CANCER, 2002, 2 (10) :750-763
[3]  
[Anonymous], 2020, CA Cancer J Clin, DOI DOI 10.3322/CAAC.21590
[4]   The isoelectric points of lecithin and sphingomyelin. [J].
Chain, E ;
Kemp, I .
BIOCHEMICAL JOURNAL, 1934, 28 :2052-2055
[5]   To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery [J].
Danhier, Fabienne ;
Feron, Olivier ;
Preat, Veronique .
JOURNAL OF CONTROLLED RELEASE, 2010, 148 (02) :135-146
[6]   Nanoparticle therapeutics: an emerging treatment modality for cancer [J].
Davis, Mark E. ;
Chen, Zhuo ;
Shin, Dong M. .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (09) :771-782
[7]   A Tumor-Acidity-Activated Charge-Conversional Nanogel as an Intelligent Vehicle for Promoted Tumoral-Cell Uptake and Drug Delivery [J].
Du, Jin-Zhi ;
Sun, Tian-Meng ;
Song, Wen-Jing ;
Wu, Juan ;
Wang, Jun .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2010, 49 (21) :3621-3626
[8]   Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein [J].
Ekins, S ;
Kim, RB ;
Leake, BF ;
Dantzig, AH ;
Schuetz, EG ;
Lan, LB ;
Yasuda, K ;
Shepard, RL ;
Winter, MA ;
Schuetz, JD ;
Wikel, JH ;
Wrighton, SA .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :964-973
[9]   Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates [J].
Ekins, S ;
Kim, RB ;
Leake, BF ;
Dantzig, AH ;
Schuetz, EG ;
Lan, LB ;
Yasuda, K ;
Shepard, RL ;
Winter, MA ;
Schuetz, JD ;
Wikel, JH ;
Wrighton, SA .
MOLECULAR PHARMACOLOGY, 2002, 61 (05) :974-981
[10]   Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: Studies with human gastro-entero-pancreatic ectopic tumor models [J].
Gabizon, Alberto ;
Amitay, Yasmine ;
Tzemach, Dina ;
Gorin, Jenny ;
Shmeeda, Hilary ;
Zalipsky, Samuel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :245-253